Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint

(NASDAQ:MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the ...
The Daily Reporter

McCordsville officials looks toward next phase of McCord Square development

Town leaders are looking to begin the second phase of development of McCord Square soon as the new town center comes to life.
TipRanks on MSN

Amgen’s Phase 3 Study on Rocatinlimab: A Potential Game-Changer for Prurigo Nodularis

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a Phase 3 clinical study ...
TipRanks on MSN

Amgen’s Promising Phase 3 Study on Blinatumomab for Leukemia: What Investors Need to Know

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is currently conducting a Phase 3 ...

First Alzheimer's pill for genetically at high risk shows promise in phase 3 trial

Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...
Fierce Biotech

Roche claws its way toward FDA as phase 3 eye disease trials yield mixed results

Roche believes it has exited phase 3 with data to support talks with regulatory agencies, but the mixed results raise ...
Fierce Pharma

Merck grows more ambitious about 'workhorse' TROP2 ADC as partner Kelun posts phase 3 wins

Oct. 14, days before the 2025 European Society for Medical Oncology (ESMO) Congress in Berlin, Merck & Co. | Merck has just ...
Fierce Pharma

Novartis advances IgAN efforts with phase 3 win for Fabhalta, plots FDA filing for full approval

Novartis has spent considerable time and energy building its presence in the IgA nephropathy (IgAN) disease area, and now | ...

Johnson & Johnson Reports Strong Phase 3 Results For Multiple Myeloma Therapy

Tecvayli combined with Darzalex Faspro improves overall survival in relapsed/refractory multiple myeloma, Johnson & Johnson ...
Fierce Biotech

Neuphoria nixes social anxiety program and starts strategic review after phase 3 flop

The program in question is Neuphoria’s BNC210, also known as soclenicant, an α7 nicotinic receptor negative alteration ...
carolinacoastonline.com

County budgets $400,000 in RCCP funds for Phase 3 work

The Carteret County Board of Commissioners has approved a budget amendment appropriating $400,000 in grant funds for ...
The Manila Times

Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference

FDA-approved Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) is available in the United States for the treatment of inflammatory ...